Executive Medical Director, Clinical Development - Berkeley, CA

Scorpion Therapeutics; Berkeley (CA); Hybrid; USD 280,000 - 440,000; Full time

Job summary

Ray Therapeutics seeks an Executive Medical Director in Clinical Development to provide strategic and operational leadership for ophthalmology-focused clinical programs, including RTx-015 for retinitis pigmentosa. You will develop clinical strategies, oversee trial design, monitor safety and data, and represent the company externally.

The role requires an MD/DO with 7–10 years in biotech or pharma, with deep expertise in ophthalmology and neuroscience, and extensive experience in clinical

Qualifications

• MD/DO required with 7–10 years in biotech or pharma.
• Expertise in ophthalmology and neuroscience.
• Experience in clinical development across phases, including regulatory submissions and registrational trials.

Responsibilities

• Develop clinical strategies for ophthalmology-focused programs.
• Oversee trial design, safety monitoring, and data interpretation.
• Represent the company externally and mentor clinical staff.
• Collaborate with Regulatory, Clinical Ops, Safety, and Commercial teams.

Skills

Ophthalmology

Neuroscience

Clinical development

Regulatory submissions

Education

MD/DO

Job description

Role: Executive Medical Director, Clinical Development at Ray Therapeutics, providing strategic and operational leadership for ophthalmology-focused clinical programs, including RTx-015 for retinitis pigmentosa.

Responsibilities: develop clinical strategies, oversee trial design, monitor safety and data, interpret emerging results, and represent the company externally. Collaborate with cross-functional teams (Regulatory, Clinical Ops, Safety, Commercial), support regulatory interactions, and mentor clinical staff.

Qualifications: MD/DO with 7-10 years in biotech or pharma, expertise in ophthalmology/neuroscience, experience in clinical development across phases, including regulatory submissions and registrational trials.

High-Value: ophthalmology, retina, neuro-ophthalmology, retinal degenerative diseases, biologics/AAV gene therapies, early to late-stage development, GxP compliance, clinical trial design, and cross-functional leadership.

WorkSetup: hybrid in Berkeley, CA, with a requirement of three days onsite.